Literature DB >> 2229649

Defective DNA repair in cultured melanocytes from xeroderma pigmentosum patients.

J Yamaguchi1, A Mamada, S Kondo, Y Satoh.   

Abstract

The DNA repair of ultraviolet (UV)-induced damages in primary cultured melanocytes from xeroderma pigmentosum (XP) patients and normal subjects were studied by measuring unscheduled DNA synthesis (UDS) on autoradiographs. Melanocytes were cultured in alpha-minimum essential medium (alpha-MEM) supplemented with 10% fetal calf serum (FCS), 12-O-tetradecanoyl-phorbol-13 acetate (TPA), and geneticin. The levels of UDS in XP melanocytes were compared with those in normal melanocytes. In both normal and XP melanocytes, post-UV-UDS increased dose-dependently at doses of 5-10 J/m2. XP melanocytes exhibited various levels of defect in DNA repair, depending on the type of XP. Melanocytes from XP-A patients displayed very low levels of UDS, only 6.2-8.4% that of the normal melanocytes. However, UDS values in melanocytes from intermediate groups, XP-D, XP-E, and XP-F, were relatively high, 37.2-53.5% of the control in XP-D, 50.0-66.5% in XP-E, and 38.2-46.7% in XP-F, respectively. Melanocytes from XP-variant patients exhibited almost normal levels of UDS, 87.7-91.6% of those from normal subjects. The levels of UDS in XP melanocytes were very similar to those in fibroblasts isolated from the same specimens.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2229649     DOI: 10.1111/j.1346-8138.1990.tb01677.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  1 in total

1.  ERCC4 variants identified in a cohort of patients with segmental progeroid syndromes.

Authors:  Takayasu Mori; Matthew J Yousefzadeh; Maryam Faridounnia; Jessica X Chong; Fuki M Hisama; Louanne Hudgins; Gabriela Mercado; Erin A Wade; Amira S Barghouthy; Lin Lee; George M Martin; Deborah A Nickerson; Michael J Bamshad; Laura J Niedernhofer; Junko Oshima
Journal:  Hum Mutat       Date:  2017-11-17       Impact factor: 4.878

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.